• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用表达霍乱弧菌O抗原的伤寒沙门氏菌Ty21a克隆进行口服免疫:人体血清杀菌抗体反应与免疫前抗体水平的关系。

Oral immunization with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O-antigen: serum bactericidal antibody responses in man in relation to pre-immunization antibody levels.

作者信息

Attridge S

机构信息

Department of Microbiology & Immunology, University of Adelaide, South Australia.

出版信息

Vaccine. 1991 Dec;9(12):877-82. doi: 10.1016/0264-410x(91)90007-s.

DOI:10.1016/0264-410x(91)90007-s
PMID:1725837
Abstract

Previous studies have shown that oral immunization with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O-antigen elicits serum antibody responses against the foreign polysaccharide in human volunteers. These responses are conveniently assayed by complement-dependent bacteriolysis of V. cholerae. In this report the bactericidal responses generated by two such clones are analysed in relation to the pre-immunization titres of various serum antibodies. A significant association was found, in that recipients with higher prevaccine titres of anti-V. cholerae bactericidal antibodies were less likely to register significant bactericidal responses following immunization. These results are discussed in relation to the concept of vaccine exclusion.

摘要

先前的研究表明,用表达霍乱弧菌O抗原的伤寒沙门氏菌Ty21a克隆进行口服免疫可在人类志愿者中引发针对外源多糖的血清抗体反应。这些反应可通过霍乱弧菌的补体依赖性细菌溶解方便地进行检测。在本报告中,分析了两个这样的克隆产生的杀菌反应与各种血清抗体的免疫前滴度的关系。发现了一种显著的关联,即免疫前抗霍乱弧菌杀菌抗体滴度较高的接受者在免疫后产生显著杀菌反应的可能性较小。结合疫苗排除的概念对这些结果进行了讨论。

相似文献

1
Oral immunization with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O-antigen: serum bactericidal antibody responses in man in relation to pre-immunization antibody levels.用表达霍乱弧菌O抗原的伤寒沙门氏菌Ty21a克隆进行口服免疫:人体血清杀菌抗体反应与免疫前抗体水平的关系。
Vaccine. 1991 Dec;9(12):877-82. doi: 10.1016/0264-410x(91)90007-s.
2
In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans.
Vaccine. 1991 Jul;9(7):515-20. doi: 10.1016/0264-410x(91)90039-9.
3
Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen.EX880的特性与免疫原性,EX880是一种基于伤寒沙门氏菌Ty21a的克隆株,可产生霍乱弧菌O抗原。
Infect Immun. 1991 Jul;59(7):2279-84. doi: 10.1128/iai.59.7.2279-2284.1991.
4
The antibody response to an oral Ty21a-based typhoid-cholera hybrid is unaffected by prior oral vaccination with Ty21a.
J Infect Dis. 1992 Jan;165(1):182-3. doi: 10.1093/infdis/165.1.182.
5
Immunisation against cholera with a Ty21a-cholera hybrid.
Ann Sclavo Collana Monogr. 1986;3(1-2):143-7.
6
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.源自伤寒杆菌Ty21a的伤寒-霍乱杂交疫苗在人体中的安全性、免疫原性及抗霍乱攻击效力。
Infect Immun. 1990 Jun;58(6):1620-7. doi: 10.1128/iai.58.6.1620-1627.1990.
7
Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.评估伤寒沙门菌Ty21a和霍乱弧菌CVD 103-HgR联合口服活疫苗安全性和免疫原性的随机、双盲、安慰剂对照试验。
Infect Immun. 1996 Apr;64(4):1454-7. doi: 10.1128/iai.64.4.1454-1457.1996.
8
A review of the current status of enteric vaccines.肠道疫苗现状综述
P N G Med J. 1995 Dec;38(4):325-31.
9
Local and systemic immune responses to combined vibrio cholerae CVD103-HgR and salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization.霍乱弧菌CVD103-HgR与伤寒沙门氏菌Ty21a联合口服活疫苗初次免疫和再次免疫后的局部和全身免疫反应
Vaccine. 2000 Jul 1;18(26):3031-9. doi: 10.1016/s0264-410x(00)00101-8.
10
Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.口服侵袭性和非侵袭性减毒活细菌进行初次免疫和加强免疫后人体的黏膜和全身免疫反应
Infect Immun. 1999 Jul;67(7):3680-5. doi: 10.1128/IAI.67.7.3680-3685.1999.

引用本文的文献

1
Enteric pathogens as vaccine vectors for foreign antigen delivery.作为用于递送外源抗原的疫苗载体的肠道病原体。
Infect Immun. 2004 Oct;72(10):5535-47. doi: 10.1128/IAI.72.10.5535-5547.2004.
2
Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139.用于检测霍乱弧菌O139杀菌抗体的灵敏微孔板检测法。
Clin Diagn Lab Immunol. 2002 Mar;9(2):383-7. doi: 10.1128/cdli.9.2.383-387.2002.
3
Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.
抗载体免疫抑制了用多糖-蛋白质偶联物经鼻免疫后对多糖抗原的抗体反应。
Infect Immun. 1997 May;65(5):1579-83. doi: 10.1128/iai.65.5.1579-1583.1997.
4
Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.鼠胃肠道中的铜绿假单胞菌清除是由O抗原特异性循环抗体有效介导的。
Infect Immun. 1995 Aug;63(8):2818-25. doi: 10.1128/iai.63.8.2818-2825.1995.